We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.9B
AUM Growth
+$1.63B
Cap. Flow
-$1.42B
Cap. Flow %
-4.19%
Top 10 Hldgs %
15.42%
Holding
3,077
New
93
Increased
384
Reduced
2,402
Closed
59

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$41.6M
2
XOM icon
ExxonMobil
XOM
+$33.5M
3
DELL
DELL INC
DELL
+$27.8M
4
GE icon
GE Aerospace
GE
+$22.8M
5
IBM icon
IBM
IBM
+$19M

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Technology 13.93%
3 Healthcare 12.71%
4 Industrials 11.47%
5 Energy 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRTX
2976
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$81K ﹤0.01%
22
GMAN
2977
DELISTED
Gordmans Stores, Inc.
GMAN
$80K ﹤0.01%
10,438
-600
-5% -$5.64K
ALIM
2978
DELISTED
Alimera Sciences
ALIM
$76K ﹤0.01%
1,081
-6
-0.6% -$245
DS
2979
DELISTED
Drive Shack Inc.
DS
$76K ﹤0.01%
14,565
CYTK icon
2980
Cytokinetics
CYTK
$10.5B
$74K ﹤0.01%
11,377
+1,100
+11% +$7.23K
IMI
2981
DELISTED
Intermolecular, Inc.
IMI
$74K ﹤0.01%
14,997
SWSH
2982
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
$73K ﹤0.01%
14,245
-1,010
-7% -$5.81K
FCSC
2983
DELISTED
Fibrocell Science Inc.
FCSC
$71K ﹤0.01%
1,163
+180
+18% +$10.5K
RSYS
2984
DELISTED
Radisys Corp
RSYS
$68K ﹤0.01%
29,842
-2,050
-6% -$5.45K
LLEN
2985
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
$68K ﹤0.01%
40,733
FOLD
2986
DELISTED
Amicus Therapeutics
FOLD
$67K ﹤0.01%
28,706
SID icon
2987
Companhia Siderúrgica Nacional
SID
$1.31B
$67K ﹤0.01%
+10,800
New +$59K
ENZN
2988
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$66K ﹤0.01%
56,785
-3,300
-5% -$5.08K
XBKS
2989
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$64K ﹤0.01%
3,649
-300
-8% -$4.55K
ACFN
2990
DELISTED
Acorn Energy Inc
ACFN
$64K ﹤0.01%
15,714
KIOR
2991
DELISTED
KIOR, INC CLASS A COM STK
KIOR
$64K ﹤0.01%
38,069
KGC icon
2992
Kinross Gold
KGC
$27.4B
$62K ﹤0.01%
+14,050
New +$67K
BXC icon
2993
BlueLinx
BXC
$422M
$57K ﹤0.01%
2,934
GGS
2994
DELISTED
GLOBAL GEOPHYSICAL SERVICES, INC COM STK
GGS
$54K ﹤0.01%
33,805
-1,900
-5% -$3.79K
FBIO icon
2995
Fortress Biotech
FBIO
$104M
$53K ﹤0.01%
1,340
CYNI
2996
DELISTED
CYAN INC COM
CYNI
$53K ﹤0.01%
10,029
-250
-2% -$1.49K
KSPN
2997
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$49K ﹤0.01%
555
-50
-8% -$4.34K
PTX
2998
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$47K ﹤0.01%
1,847
-160
-8% -$3.81K
PT
2999
DELISTED
PORTUGAL TELECOM SGPS, S.A.
PT
$46K ﹤0.01%
+10,595
New +$47.6K
TGTX icon
3000
TG Therapeutics
TGTX
$7.96B
$44K ﹤0.01%
11,246
-300
-3% -$1.21K

Similar funds

RhumbLine Advisers's Q4 2013 Portfolio in Review

As of Q4 2013, RhumbLine Advisers held 3,077 positions worth $33.9B, up 5% from $32.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.42B in Q4 2013, closing 59 positions and reducing 2,402 holdings. Its most notable exit was NYSE EURONEXT INC, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Transocean worth $12.5M.

  • RhumbLine Advisers's largest Q4 2013 buy was Transocean: 252,714 shares worth $12.5M.
  • RhumbLine Advisers added most to Meta Platforms (Facebook) in Q4 2013, an estimated $50.1M increase.
  • RhumbLine Advisers's biggest Q4 2013 reduction was Apple, cutting an estimated $41.6M.
  • RhumbLine Advisers fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $15.2M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.9B portfolio in Q4 2013.
  • RhumbLine Advisers opened 93 new positions and closed 59 in Q4 2013.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $33.9B.

Based on RhumbLine Advisers's 13F filing for Q4 2013, filed 3 Feb 2014.